[Cost-utility analysis of two formulations of botulinum toxin type A in the treatment of blepharospasm and cervical dystonia in Spain]

Autor: A, Sanz-Granda, M J, Marti, M J, Catalan

Publikováno v: Revista de neurologia. 67(12)

Studies on focal dystonia showed that the formulations of botulinum toxin type A, incobotulinumtoxin-A (Inco-BTA) and onabotulinumtoxin-A (Ona-BTA), have equivalent efficacy and safety.To carry-out a cost-utility analysis of Inco-BTA administered on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::53017b14feba03b3ed0b1f1788bf7b36
https://pubmed.ncbi.nlm.nih.gov/30536360

Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson's disease

Autor: M.C. Carrasco-Lopez, M. J. Catalan-Alonso, N. López-Ariztegui, Antonio Oliviero, Guglielmo Foffani, J. C. Segundo-Rodriguez, Laura Mordillo-Mateos, Michele Dileone, Jose A. Obeso, Fernando Alonso-Frech

Publikováno v: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)

Transcranial static magnetic field stimulation (tSMS) is a recent low-cost non-invasive brain stimulation technique that decreases cortical excitability in healthy subjects. The objective of the present study was to test the ability of tSMS to modula

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01da880583b0155e10738c211123afc1
https://hdl.handle.net/20.500.12530/31317

P037 Transcranial static magnetic field stimulation-induced modulation of motor cortex excitability in Parkinson’s disease

Autor: Fernando Alonso-Frech, M. J. Catalan-Alonso, J. C. Segundo-Rodriguez, Antonio Oliviero, Guglielmo Foffani, Jose A. Obeso, N. López-Aristegu, M.C. Carrasco-Lopez, Michele Dileone, L. Mordillo Mateos

Publikováno v: Clinical Neurophysiology. 128:e26

Question tSMS is a new non-pharmacological, low-cost, non-invasive brain stimulation (NIBS) technique that decreases cortical excitability in healthy subjects. The effects of tSMS in Parkinson’s disease remain unknown. We designed this study to tes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::22fafc24d9fd29098acae144652f292c
https://doi.org/10.1016/j.clinph.2016.10.165

Association of a thyrotropin-secreting pituitary adenoma and a thyroid follicular carcinoma

Autor: E. Yuste, J. A. Cabranes, J. Uria, Jesús Argente, Martin Pj, T. Aramendi, Aniceto Charro, M. L. Garcia-Mauriño, M. J. Catalan, A. L. Calle-Pascual

Publikováno v: Journal of Endocrinological Investigation. 14:499-502

The different factors involved as etiological agents in thyroid cancer have in common long term thyroid follicle stimulation. On this base, a patient with a TSH-producing pituitary adenoma could be at high risk for developing thyroid cancer. A patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd97c4046c32373d4924431cda54fa99
https://doi.org/10.1007/bf03346852

[Dopaminomimetic psychosis in Parkinson's disease: first symptom of early dementia?]

Autor: M J, Catalan-Alonso, J, Del Val

Publikováno v: Revista de neurologia. 32(11)

Parkinson s disease (PD) is caused by an abnormal degeneration of the dopamine producing cells in the substantia nigra and ventral tegmental area. When PD advances, degeneration of the nigroestriatal tracts may expand and involve other pathways (meso

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1f381a4ba52b510063e362d78734d6a6
https://pubmed.ncbi.nlm.nih.gov/11562835